News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Nov 1, 2013 Insmed Appoints David W.J. McGirr to Its Board of Directors Oct 23, 2013 Insmed to Host Third Quarter 2013 Financial Results Conference Call on Tuesday, November 5, 2013 Oct 15, 2013 Insmed Completes Enrollment of Phase 2 Clinical Trial of ARIKACE to Treat Nontuberculous Mycobacteria Lung Disease in U.S. and Canada Sep 15, 2013 Insmed to Present at Leerink Swann Rare Disease Roundtable Sep 11, 2013 Insmed Fortifies Global Patent Portfolio Sep 4, 2013 Insmed to Participate in the Stifel Healthcare Conference 2013 Aug 7, 2013 Insmed to Participate in August Investor Conferences Aug 6, 2013 Insmed Reports Second Quarter Financial Results Jul 31, 2013 Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013 Jul 29, 2013 Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary Show 5102550100 per page«1…31323334353637…70» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download